Literature DB >> 19779337

The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease.

Tetsuhiro Tanaka1, Masaomi Nangaku.   

Abstract

PURPOSE OF REVIEW: Tubulointerstitial hypoxia in the kidney has been considered a hallmark of injury and mediator of disease progression. This review focuses on hypoxia-inducible factor (HIF)-1, a master transcription factor in cellular adaptation to hypoxia. RECENT
FINDINGS: HIF-1alpha is expressed in the hypoxic tubular epithelium as well in as the papillary interstitium and glomerular epithelial cells. Although HIF-1 plays a protective role in a number of acute kidney injury models when overexpressed, its activation in chronic kidney disease results in multiple phenotypic changes, depending on the pathological context.
SUMMARY: Hypoxia, especially HIF-1, is a critical mediator in the pathogenesis of chronic kidney disease. Underlying molecular mechanisms, together with responsible HIF target genes, are currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19779337     DOI: 10.1097/MNH.0b013e3283328eed

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  31 in total

Review 1.  Metabolic control of renin secretion.

Authors:  János Peti-Peterdi; Haykanush Gevorgyan; Lisa Lam; Anne Riquier-Brison
Journal:  Pflugers Arch       Date:  2012-06-23       Impact factor: 3.657

Review 2.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

3.  The role of Sirt1 in renal rejuvenation and resistance to stress.

Authors:  Karl A Nath
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 4.  The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease.

Authors:  Imari Mimura; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 5.  Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.

Authors:  Reiko Inagi; Yu Ishimoto; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2014-04-22       Impact factor: 28.314

6.  Aberrant tubuloglomerular feedback and HIF-1α confer resistance to ischemia after subtotal nephrectomy.

Authors:  Prabhleen Singh; Roland C Blantz; Christian Rosenberger; Francis B Gabbai; Trenton R Schoeb; Scott C Thomson
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

Review 7.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

8.  Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Amrutesh S Puranik; Hui Tang; Kelly A McGurren; Andre J van Wijnen; Amir Lerman; Lilach O Lerman
Journal:  Kidney Int       Date:  2017-02-24       Impact factor: 10.612

Review 9.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

10.  DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.

Authors:  Yu-Ting Chang; Ching-Chin Yang; Szu-Yu Pan; Yu-Hsiang Chou; Fan-Chi Chang; Chun-Fu Lai; Ming-Hsuan Tsai; Huan-Lun Hsu; Ching-Hung Lin; Wen-Chih Chiang; Ming-Shiou Wu; Tzong-Shinn Chu; Yung-Ming Chen; Shuei-Liong Lin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.